The medicinal landscape in the nation is increasingly characterized by a pattern toward market dominance, with a handful of large companies wielding significant control. These sector giants, often bolstered by extensive distribution networks and strong brand recognition, present a complex picture for competition and accessible healthcare. While som

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces growing concerns about monopolies. A few dominant players control a significant share of the market, potentially restricting competition and driving up prices for consumers. This situation raises doubts about the long-term impact on patient access to affor